VitaNova Life Sciences Corporation (VNOV)

Revenue by Segment

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017
Healthy Food Products	1.06M	-	-	-	-
Dietary Supplement Segment	1.95M	2.65M	544.59K	-	-
Consulting Services Segment	15.00K	10.84K	26.10K	38.00K	120.00K
Total	3.03M	2.66M	570.69K	38.00K	120.00K

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017
Unites States Of America	2.68M	1.20M	77.85K	38.00K	-
China	-	385.72K	411.10K	-	-
Hong Kong	345.58K	1.07M	81.75K	-	-
Total	3.03M	2.66M	570.69K	38.00K	-

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error